Brett A Grimaud - 20 May 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, GEN COUNSEL AND SECRETARY
Signature
/s/ Brett A. Grimaud
Issuer symbol
TBPH
Transactions as of
20 May 2024
Net transactions value
-$84,339
Form type
4
Filing time
22 May 2024, 18:04:53 UTC
Previous filing
04 Apr 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $84,339 -9,268 -2.6% $9.10 351,881 20 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 Includes 465 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2024.